UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14C INFORMATION

Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

 

Check the appropriate box:

o

Preliminary Information Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2))

x

Definitive Information Statement

 

HEARTSTAT TECHNOLOGY, INC.

(Name of Registrant As Specified in its Charter)

 

Payment of Filing Fee (Check the appropriate box):

x

No fee required.

o

Fee computed on table below per Exchange Act Rule 14c-5(g) and 0-11.

 

1)

Title of each class of securities to which transaction applies:                                      

 

2)

Aggregate number of securities to which transaction applies:                                           

 

3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):                                    

 

4)

Proposed maximum aggregate value of transaction:                                                          

 

5)

Total fee paid:                                                                                        

o

Fee paid previously with preliminary materials

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

1)

Amount Previously Paid:                                                      

 

2)

Form, Schedule or Registration Statement No.:                                                       

 

3)

Filing Party:                                                      

 

4)

Date Filed:                                                       

 

 

 

 

 

 

HEARTSTAT TECHNOLOGY, INC.

530 Wilshire Blvd, #304

Santa Monica, California 90401

(310) 451-7400

 

INFORMATION STATEMENT

CORPORATE ACTION TO BE TAKEN EFFECTIVE MARCH 1, 2006

 

INTRODUCTION

 

This Information Statement will be first sent or given to shareholders on or about February 9, 2006, in connection with corporate action to be taken effective March 1, 2006. HeartSTAT Technology, Inc. (the “Company”) has adopted an amendment to its Certificate of Incorporation, which has an effective date of March 1, 2006.

**We Are Not Asking You for a Proxy and You are Requested Not to Send Us a Proxy.**

VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF

Voting Securities

Shareholders of the Company have adopted the amendment to the Certificate of Incorporation by means of a written consent dated February 6, 2006. On that date, 67,402,887 shares of Common Stock were issued and outstanding.

Voting Rights and Requirements

Consent from the holders of a majority of the shares outstanding was required to adopt the amendment to the Certificate of Incorporation.

Principal Security Holders

The following table sets forth information, as February 6, 2006, with respect to the beneficial ownership of the Company’s Common Stock by each person known by the Company to be the beneficial owner of more than five percent of the outstanding Common Stock and by directors and officers of the Company, both individually and as a group:

 

 

Beneficial Owners

 

Shares Owned Beneficially and of Record

 

Percent of Class (1)

David James Curd

1600 W 25th Street

Miami Beach, FL 33140

 

40,000,000

59.3%

Garrett K. Krause

23852 PCH, #736

Malibu, CA 90265

 

15,000,000 (2)

22.3%

 

 

HeartSTAT Technology, Inc. Information Statement - Page 1 of 2

 

 

 

 

 

Beneficial Owners

 

Shares Owned Beneficially and of Record

 

Percent of Class (1)

Solution Med Ventures

C/o G.K. Krause

1521 Alton Road, #352

Miami Beach, FL 33139

 

4,000,000 (2)

5.9%

FutureVest MicroCap Fund

C/o G.K. Krause

1521 Alton Road, #352

Miami Beach, FL 33139

 

4,000,000 (2)

5.9%

Diamond Ventures

C/o G.K. Krause

1521 Alton Road, #352

Miami Beach, FL 33139

 

4,000,000 (2)

5.9%

EAngels Technology Fund

C/o G.K. Krause

1521 Alton Road, #352

Miami Beach, FL 33139

 

3,000,000 (2)

4.4%

David P. Over

0

-

Officers and directors as a group

(2 persons)

40,000,000

59.3%

__________

(1)

Based on 67,402,887 shares outstanding. If a person listed on this table has the right to obtain additional shares of common stock within 60 days from February 6, 2006, the additional shares are deemed to be outstanding for the purpose of computing the percentage of class owned by such person, but are not deemed to be outstanding for the purpose of computing the percentage of any other person.               

 

(2)

Includes 4,000,000 shares owned of record by FutureVest MicroCap Fund; 4,000,000 shares owned by SolutionMed Ventures; 4,000,000 shares owned by Diamond Ventures; and 3,000,000 shares owned by eAngels Technology Fund. Garrett K. Krause is an investment manager that manages equity investments and partnerships for the eAngels Syndicate of investors. Mr. Garrett K. Krause is deemed the beneficial owner of a total of 15,000,000 shares or 22.3% of the total outstanding shares of common stock.

 

Changes in Control

 

As of November 1, 2005, we issued 40,000,000 shares to David James Curd as full and complete payment of debt in the amount of $243,380.77.

 

AMENDMENT TO THE CERTIFICATE OF INCORPORATION

 

The Company has determined to amend its Certificate of Incorporation by changing its name to Verdant Technology Corporation.

 

Management believes that this new name will more clearly reflect the Company’s new business focus, as the Company sold the assets relating to the “HeartSTAT Technology” in October 2005.

 

 

HeartSTAT Technology, Inc. Information Statement - Page 2 of 2